Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate Data

Overview of attention for article published in Journal of Clinical Medicine, June 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 15,435 followers.

RT @Texas_Heart: Meta-analysis of percutaneous endomyocardial cell therapy in patients with ischemic heart failure by combination of indivi…

Meta-analysis of percutaneous endomyocardial cell therapy in patients with ischemic heart failure by combination of individual patient data (IPD) of ACCRUE and publication-based aggregate data | #THIPubs @Stemcell_doc | @JCM_MDPI https://t.co/qvpfrossLR…

RT @JThorball: Heart Failure [HFrEF]: Meta-analysis of percutaneous endomyocardial cell therapies (stem cells) in patients with ischemic h…

Heart Failure [HFrEF]: Meta-analysis of percutaneous endomyocardial cell therapies (stem cells) in patients with ischemic heart failure demonstrates good effect: improvement in left ventricular function and reduction in mortality. @RigiCare https://t.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.